VJHemOnc is committed to improving our service to you

SOHO 2020 | Horizon scan of CAR-T for lymphoma

VJHemOnc is committed to improving our service to you

Sattva S Neelapu

Sattva S Neelapu, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, provides an overview of the current lymphoma treatment landscape of CAR T-cell therapies in lymphoma and highlights its benefits, including long-term remissions. Dr Neelapu also explores unmet needs in this area, including the development of allogenic off-the-shelf CAR T-cell therapies. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter